FDA issues draft guidelines on pre-market testing of addictive drugs

01/27/2010 | Sun (Baltimore), The

The FDA released draft guidelines to help drug firms widen their criteria for determining whether an experimental drug could lead to abuse. Biochemistry and chemistry advances have increased the chance that drugs might have unrecognized potential for abuse, the agency said. The final guidelines will be released after two months of consultation with the public and the drug industry.

View Full Article in:

Sun (Baltimore), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA